OSRH
OSRH
NASDAQ · Biotechnology

Osr Holdings Inc

$0.59
+0.02 (+3.77%)
As of May 16, 2:28 AM ET ·
Financial Highlights (FY 2026)
Revenue
5.02M
Net Income
-31,136,381
Gross Margin
20.4%
Profit Margin
-619.8%
Rev Growth
D/E Ratio
0.06
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 20.4% 63.7% 63.7% 63.7%
Operating Margin -631.0% -24.9% -26.5% -25.5%
Profit Margin -619.8% -25.6% -22.6% -20.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.02M 7.84M 7.68M 7.81M
Gross Profit 1.02M 5.00M 4.89M 4.98M
Operating Income -31,698,913 -1,953,454 -2,038,506 -1,995,236
Net Income -31,136,381 -2,005,672 -1,738,578 -1,581,297
Gross Margin 20.4% 63.7% 63.7% 63.7%
Operating Margin -631.0% -24.9% -26.5% -25.5%
Profit Margin -619.8% -25.6% -22.6% -20.2%
Rev Growth +12.8% +0.1% +6.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 526.2K 1.67M 1.99M 1.69M
Total Equity 9.41M 9.75M 9.93M 10.19M
D/E Ratio 0.06 0.17 0.20 0.17
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -49,165,725 -2,263,216 -2,551,790 -2,649,024
Free Cash Flow -1,406,564 -1,071,377 -1,645,390